NCT01457261 - IPF Drug Deposition Study | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

November 30, 2014

Study Completion Date

November 30, 2014

Conditions

Idiopathic Pulmonary Fibrosis

Interventions

DRUG

Salbutamol

Radiolabelled salbutamol to be administered as a monodisperse particle via a spinning top aerosol generator or else as a polydisperse mist via a nebuliser or metered dose inhaler.

Trial Locations (1)

SW3 6NP

Royal Brompton Hospital, London